← All companies

BNTX

BioNTech SE

BNTX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$92.25

-0.60 -0.65%

Key statistics

from XBRL data in SEC filings

Market cap

$23.2B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$79.52 – $124.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Aug 3, 2026 20-F/A Jul 30, 2026 6-K Jul 29, 2026 6-K Jun 8, 2026 6-K Jun 1, 2026 6-K May 22, 2026 6-K May 15, 2026 6-K May 7, 2026 6-K May 5, 2026 6-K May 5, 2026 6-K Apr 13, 2026 6-K Apr 2, 2026 20-F/A Apr 1, 2026 6-K Mar 24, 2026 20-F Mar 10, 2026 6-K Mar 10, 2026 6-K Mar 10, 2026 6-K Jan 28, 2026 6-K Jan 14, 2026 6-K Jan 12, 2026 6-K Jan 6, 2026 6-K Dec 18, 2025 6-K Dec 9, 2025 6-K Dec 8, 2025 6-K Dec 3, 2025 6-K Nov 26, 2025 6-K Nov 12, 2025 6-K Nov 3, 2025 6-K Nov 3, 2025 6-K Oct 22, 2025 6-K Oct 1, 2025 6-K Sep 8, 2025 6-K Sep 8, 2025 6-K Sep 5, 2025 6-K Aug 27, 2025 6-K Aug 11, 2025 6-K Aug 4, 2025 6-K Aug 4, 2025 6-K Jul 25, 2025 6-K Jul 17, 2025